World's Best Scientists 2026 revealed!
Gabriela Riemekasten

Gabriela Riemekasten

D-Index & Metrics

Immunology

D-Index
73
Citations
28052
World Ranking
2089
National Ranking
144

Gabriela Riemekasten publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gabriela Riemekasten sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 252 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Gabriela Riemekasten D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gabriela Riemekasten sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 73 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Gabriela Riemekasten is affiliated with the University of Lübeck in Germany and has contributed extensively to the field of medicine, with a focus on specialty areas such as pathology and forensic medicine, immunology, pulmonary and respiratory medicine, rheumatology, and molecular biology.

Their research predominantly centers on systemic sclerosis and related diseases, alongside significant work in interstitial lung diseases and idiopathic pulmonary fibrosis. Other major topics include mast cells and histamine, dermatologic treatments and research, inflammatory myopathies and dermatomyositis, urticaria and related conditions, and systemic lupus erythematosus research.

Frequent co-authors in their publications include Harald Heidecke, Elise Siegert, Oliver Distler, Peter Lamprecht, and Jens Y. Humrich, indicating ongoing collaboration within their research community.

Gabriela Riemekasten has published regularly in several venues notable for rheumatology and immunology research. These include:

  • Annals of the Rheumatic Diseases (30 publications)
  • Lara D. Veeken (15 publications)
  • Frontiers in Immunology (13 publications)
  • Zeitschrift für Rheumatologie (11 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (9 publications)

Significant papers authored or co-authored cover clinical trials and disease mechanisms, reflecting a range of emphases within systemic sclerosis and related inflammatory conditions. Selected recent publications include:

  • "Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial," 2020, The Lancet Respiratory Medicine
  • "Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database," 2020, Annals of the Rheumatic Diseases
  • "Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases," 2021, Frontiers in Immunology
  • "Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases," 2022, Frontiers in Medicine
  • "Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity," 2022, Nature Communications

The depth and breadth of Gabriela Riemekasten's scholarship, including 352 publications broadly in medicine, underscore a consistent focus on both clinical and molecular aspects of autoimmune and inflammatory diseases. Their work often intersects the diverse fields of rheumatology and pulmonary medicine, contributing data relevant to disease mechanisms and therapeutic approaches.

Best Publications

  • 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

    Frank Van Den Hoogen;Dinesh Khanna;Jaap Fransen;Sindhu R. Johnson

  • Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

    Anthony J. Tyndall;Bettina Bannert;Madelon Vonk;Paolo Airò

  • Update of EULAR recommendations for the treatment of systemic sclerosis

    Otylia Kowal-Bielecka;Jaap Fransen;Jerome Avouac;Mike Becker;Mike Becker

  • Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

    Dinesh Khanna;Christopher P Denton;Angelika Jahreis;Jacob M van Laar

  • Mapping and predicting mortality from systemic sclerosis

    Muriel Elhai;Christophe Meune;Marouane Boubaya;Jérôme Avouac

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

    Dinesh Khanna;Celia J F Lin;Daniel E Furst;Jonathan Goldin

  • Mechanisms of Autoantibody-Induced Pathology.

    Ralf J. Ludwig;Karen Vanhoorelbeke;Frank Leypoldt;Ziya Kaya

  • Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

    Suzana Jordan;Jörg H W Distler;Britta Maurer;Dörte Huscher

  • Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

    Timothy R.D.J. Radstake;Olga Y Gorlova;Blanca Rueda;Jose Ezequiel Martin

  • Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database

    Florian M P Meier;Klaus W Frommer;Robert Dinser;Ulrich A Walker

  • Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients

    Katharina Hanke;Claudia S Brückner;Cornelia Dähnrich;Dörte Huscher

  • Involvement of functional autoantibodies against vascular receptors in systemic sclerosis

    Gabriela Riemekasten;Aurélie Philippe;Melanie Näther;Torsten Slowinski

  • Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus

    Caroline von Spee-Mayer;Elise Siegert;Dimas Abdirama;Angelika Rose

  • Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database.

    Anna-Maria Hoffmann-Vold;Yannick Allanore;Margarida Alves;Cathrine Brunborg

  • Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study

    Veronika K. Jaeger;Elina G. Wirz;Yannick Allanore;Philipp Rossbach

  • Inflamed kidneys of NZB / W mice are a major site for the homeostasis of plasma cells.

    Giuliana Cassese;Steffi Lindenau;Bauke de Boer;Sergio Arce

  • Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)

    Dinesh Khanna;Christopher P Denton;Celia J F Lin;Jacob M van Laar

  • Sialic acid–binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus

    Robert Biesen;Robert Biesen;Cemal Demir;Fidan Barkhudarova;Fidan Barkhudarova;Joachim R. Grün

  • Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis

    Maureen D. Mayes;Lara Bossini-Castillo;Olga Gorlova;José Ezequiel Martin

  • The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement.

    N. Hunzelmann;E. Genth;T. Krieg;W. Lehmacher

  • Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study

    Muriel Elhai;Marine Meunier;Marco Matucci-Cerinic;Britta Maurer

Frequent Co-Authors

Christopher P. Denton
Christopher P. Denton University College London
Yannick Allanore
Yannick Allanore Université Paris Cité
Oliver Distler
Oliver Distler University of Zurich
Marco Matucci-Cerinic
Marco Matucci-Cerinic University of Florence
Ariane L. Herrick
Ariane L. Herrick University of Manchester
Paolo Airò
Paolo Airò University of Brescia
Ulf Müller-Ladner
Ulf Müller-Ladner University of Giessen
Falk Hiepe
Falk Hiepe Charité - University Medicine Berlin
Jörg H W Distler
Jörg H W Distler University of Erlangen-Nuremberg
Timothy R D J Radstake
Timothy R D J Radstake Utrecht University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens diverse career opportunities in healthcare and research. Many students interested in applying their immunology knowledge pursue nursing degrees to work closely with patient care and advanced clinical practice.

For those without a nursing background, online RN programs for non nurses offer accessible pathways to become registered nurses. These programs balance theory and clinical skills, often with flexible schedules to accommodate working professionals.

If you're looking for a quicker route into nursing, exploring accelerated nursing programs can fast-track your career advancement. These programs build on existing academic experience to prepare students for nursing licensure efficiently.

For those interested in foundational nursing roles, the easiest LPN programs to get into provide entry-level opportunities with shorter duration and focused practical training. This can be a stepping stone towards more advanced qualifications.

Additionally, becoming a family nurse practitioner is an excellent way to specialize in patient care, and the easiest FNP program options highlight accessible routes to enter this advanced practice field, where immunology expertise is highly valuable.

Best Scientists Citing Gabriela Riemekasten

Trending Scientists

Recently Published Articles